2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.

      1 ,
      Cornea
      Ovid Technologies (Wolters Kluwer Health)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To evaluate the efficacy of 0.03% tacrolimus in the treatment of corticosteroid-refractory vernal keratoconjunctivitis (VKC).

          Related collections

          Author and article information

          Journal
          Cornea
          Cornea
          Ovid Technologies (Wolters Kluwer Health)
          1536-4798
          0277-3740
          Nov 2016
          : 35
          : 11
          Affiliations
          [1 ] Cornea & Anterior Segment Services, MGM Eye Institute, Raipur, India.
          Article
          10.1097/ICO.0000000000000918
          27310883
          74417f27-889b-4817-bd50-fc9c580a161c
          History

          Comments

          Comment on this article